首页> 美国卫生研究院文献>Journal of Pharmaceutical Policy and Practice >Association between medicine Price declaration by pharmaceutical industries and retail prices in Malaysia’s private healthcare sector
【2h】

Association between medicine Price declaration by pharmaceutical industries and retail prices in Malaysia’s private healthcare sector

机译:医药行业的药品价格声明与马来西亚私人医疗保健部门的零售价格之间的关联

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundAs part of the initiatives to increase price transparency for consumers, pharmaceutical industry in Malaysia have been encouraged to declare the wholesale and recommended retail prices (RRP) of medicines to the Pharmaceutical Service Department (PSD) yearly. However, the relationship between the voluntary price reporting practices and consumers’ retail medicine price is unknown. Therefore, this study aims to evaluate the effect of the voluntary price reporting practice of pharmaceutical industry on retail medicine prices, factors that may affect consumer medicine prices in Malaysia’s private healthcare sector, and the retail medicine pricing trend over 2011–2015.
机译:背景技术作为提高消费者价格透明度的举措的一部分,鼓励马来西亚制药行业每年向药品服务部门(PSD)宣布药品的批发价和建议零售价(RRP)。但是,自愿价格报告行为与消费者的零售药品价格之间的关系尚不清楚。因此,本研究旨在评估制药业自愿性价格报告做法对零售药品价格的影响,可能影响马来西亚私人医疗保健部门消费药品价格的因素以及2011-2015年零售药品价格趋势。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号